Can essential fatty acids prevent and ameliorate post-Covid-19 long haul manifestations?

COVID-19, post-COVID and post-mRNA vaccine manifestations can result in “long haul syndrome”. I propose that long-haul syndrome is because of deficiency of essential fatty acids (EFAs) and their metabolites. EFAs and their metabolites inactivate SARS-CoV-2 virus, suppress excess cytokine formation a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Das , Undurti N., Pinelatinoamericana , Editorial de
Formato: Artículo revista
Lenguaje:Inglés
Español
Publicado: Asociación de Medicina del Estrés y Psicoinmunoneuroendocrinología 2024
Materias:
AGE
efa
Acceso en línea:https://revistas.unc.edu.ar/index.php/pinelatam/article/view/44572
Aporte de:
Descripción
Sumario:COVID-19, post-COVID and post-mRNA vaccine manifestations can result in “long haul syndrome”. I propose that long-haul syndrome is because of deficiency of essential fatty acids (EFAs) and their metabolites. EFAs and their metabolites inactivate SARS-CoV-2 virus, suppress excess cytokine formation and action, are cytoprotective, inhibit NF-kB activation and regulate cGAS-STING pathway, influence gut microbiota and their metabolism, modulate platelet, macrophage, and leukocyte function, regulate neurotransmitters secretion and function, facilitate tissue regeneration and enhance wound healing. In view of their varied actions, it is likely that EFAs are of benefit in the prevention and management of long-haul syndrome